What is planned?

• FDA will conduct "mission critical" inspections overseas but will also reassess at short notice depending on urgency and travel conditions.
• The agency is also postponing the scheduling of priority surveillance inspections abroad, planned to begin in February 2022.
• FDA will continue to conduct mission-critical inspections domestically.
• Importantly, the agency will seek to maintain remote inspections to monitor foreign manufacturers as best as possible. To do so, the FDA will continue to rely on alternative tools to keep an oversight.

Source:

FDA: January 4, Roundup